British medtech company Brainomix and Switzerland-based remote robotic surgical company Nanoflex Robotics announced the receipt of £400,000 ($420,418) and CHF 400,000 ($443,700), respectively, to co-develop an AI-assisted magnetic navigation system for stroke-related robotic surgical…
Continue Reading
What You Should Know:
GE HealthCare announced a $44M contract with the Biomedical Advanced Research and Development Authority (BARDA) —part of the Administration for Strategic Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services (HHS)—to develop and…
Continue Reading
The LungIMPACT trial – a collaborative study between UK academia, NHS hospitals and Qure.ai is now gathering real-world evidence of AI-assisted diagnosis of lung cancer.Using Qure.ai’s gXR solution, the LungIMPACT trial is triaging chest…
Continue Reading
A groundbreaking study reveals the effectiveness of liquid biopsy tests in guiding personalized treatment for non-small cell lung cancer (NSCLC) patients. Unlike conventional methods, these tests focus on circulating tumor DNA (ctDNA) levels, providing…
Continue Reading
AI, machine learning, and NLP are revolutionizing healthcare through data analysis. Premier Inc. exemplifies this transformation, showcasing how AI optimizes patient selection for trials, identifies diseases like lung cancer, and enhances dementia care. By…
Continue Reading
Dr. Jose E Vidal who is currently the CEO of CytoImmune Therapeutics, a company at the forefront of a novel natural killer cell therapy for lung cancer, currently in phase 1 clinical trials joins…
Continue Reading
A study has found that admissions and hospital bed days were both reduced by 50% for high-risk COPD patients using a digital support service, reducing the burden on over-stretched healthcare services. Using a digital support…
Continue Reading
Exo has unveiled Exo Iris, a groundbreaking handheld ultrasound device that redefines medical imaging by providing versatile, on-the-go solutions. Built on advanced silicon technology, Exo Iris offers point-of-care ultrasound (POCUS) capabilities in a compact,…
Continue Reading
In a study of 2,000 chest X-rays, radiologists proved more accurate than AI in detecting common lung diseases. AI achieved sensitivity rates similar to radiologists but produced more false positives, especially in complex cases….
Continue Reading
AstraZeneca has tied up with Institut Kanser Negara, a centre of excellence for cancer care in Malaysia, to incorporate AI medical imaging into early lung cancer screening at government clinics and hospitals. WHY IT MATTERS
Lung…
